Natera EPS NTRA
Diluted earnings per share by quarter and over the last twelve months, from 2014.
- Last 12 months, to Jun 30, 2026
- −$1.37
- Latest quarter, Q2 FY26
- −$0.47
- Fiscal year 2025
- −$1.54
Natera's earnings per share was −$1.37 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.47.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.54 | n/a |
| FY2024 | −$1.53 | n/a |
| FY2023 | −$3.80 | n/a |
| FY2022 | −$5.57 | n/a |
| FY2021 | −$5.17 | n/a |
| FY2020 | −$2.81 | n/a |
| FY2019 | −$1.81 | n/a |
| FY2018 | −$2.23 | n/a |
| FY2017 | −$2.60 | n/a |
| FY2016 | −$1.85 | n/a |
| FY2015 | −$6.33 | n/a |
| FY2014 | −$1.85 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.47 | n/a | −$1.37 | |
| Q1 FY26 | −$0.60 | n/a | −$1.64 | |
| Q4 FY25 | $0.34 | n/a | −$1.54 | |
| Q3 FY25 | −$0.64 | n/a | −$2.29 | |
| Q2 FY25 | −$0.74 | n/a | −$1.91 | |
| Q1 FY25 | −$0.50 | n/a | −$1.47 | |
| Q4 FY24 | −$0.41 | n/a | −$1.53 | |
| Q3 FY24 | −$0.26 | n/a | −$1.77 | |
| Q2 FY24 | −$0.30 | n/a | −$2.46 | |
| Q1 FY24 | −$0.56 | n/a | −$3.13 | |
| Q4 FY23 | −$0.65 | n/a | −$3.80 | |
| Q3 FY23 | −$0.95 | n/a | −$4.52 |
Against its peers
Companies in Medical - Diagnostics & Research nearest Natera's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| NTRANatera | −$1.37 | |
| AAgilent Technologies | $5.09 | +19% a year |
| IQVIQVIA | $8.06 | +17% a year |
| WATWaters | $4.01 | −64% a year |
| IDXXIDEXX Laboratories | $14.22 | +18% a year |
| ILMNIllumina | $5.38 | −32% a year |
| MTDMettler-Toledo International | $44.42 | +12% a year |
| DGXQuest Diagnostics | $9.41 | +18% a year |
| LHLabcorp | $12.09 | +33% a year |
| DHRDanaher | $5.63 | +20% a year |
| MEDPMedpace | $17.05 | +27% a year |
| Peer median | $8.73 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Natera
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.